BIOCOM for BIOCOM
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Nov 17, 2020 | $45,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Nov 17, 2020 | $45,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Advocated for additional funding for NIH, FDA, CDC and BARDA in FY2021 appropriations and coronavirus supplemental legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Copyright/Patent/Trademark CPT
Expressed support for the Bayh-Dole Act, as part of the law's 40th anniversary campaign. Expressed concerns about the misuse of "march-in rights" and compulsory licenses.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Labor Issues/Antitrust/Workplace LBR
Advocated for targeted and temporary liability protections for life science organizations
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Health Issues HCR
Sent information to House and Senate staff about the life science's industry response to covid-19 Expressed strong concerns about executive orders on most-favored nation and importation Hosted a congressional webinar "Incentivizing R&D during a pandemic" Hosted a congressional webinar "The Use of Genomics in Response to the Pandemic" Advocated for the reauthorization of the Rare Pediatric Disease Priority Review Voucher Program Expressed support for the coverage of home infusion of Medicare Part B drugs during the covid-19 pandemic. Expressed our position on domesticating the US drug supply chain Expressed our position on value-based agreements and copay accumulator programs Expressed support for expanding telehealth services Expressed support for policies that encourage the use and development of novel antibiotics to fight anti-microbial resistance (AMR)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURE FABREGA CLARK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.